Počet záznamov: 1
lenalidomid
SYS d000077269 LBL 00000nx^^^2200181-^^45^^ 005 20240119195326.8 100 $a 20190101asloy0103 ba0 152 $b mesh 250 $a lenalidomid $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $8 slo 300 1-
$a 2019 (2002) $8 eng 330 1-
$a A phthalimide and piperidone derivative that has immunomodulatory and antiangiogenic properties. It is used for the treatment of transfusion-dependent anemia in MYELODYSPLASTIC SYNDROMES, and for the treatment of MULTIPLE MYELOMA, and relapsed or refractory MANTLE CELL LYMPHOMA. $8 eng 450 $a 2,6-piperidíndion, 3-(4-amino-1,3-dihydro-1-oxo-2H- izoindol-2-yl)- $5 e $8 slo 450 $a 3-(4-amino-1-oxoizoindolín-2-yl)piperidíne-2,6-dion $5 e $8 slo 450 $a Revimid $5 e $8 slo 450 $a Revlimid $5 e $8 slo 686 $a D02.241.223.805.810.400 686 $a D03.383.621.808.519 686 $a D03.633.100.513.750.563 750 $a Lenalidomide $8 eng 801 -0
$a SK $b BA006 $c 20190310 801 -2
$a SK $b BA006 $c 20190611 980 $x M
Počet záznamov: 1